All chronical situations: 1 trials - Laufs
| cerivastatin vs placebo | No demonstrated result | | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
|---|
| cardiovascular events | no data | | Cardiovascular death | no data | | myocardial infarction (fatal and non fatal) | no data | | stroke (fatal and non fatal) | no data | | Coronary event | no data | | Non vascular death | no data | | Fatal MI | no data | | Non fatal MI | no data | | All cause death | no data | | Fatal stroke | no data | | Non fatal stroke | no data | | new-onset diabetes | no data |
TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |
All type of patients: 1 trials - Laufs
| cerivastatin vs placebo | No demonstrated result | | Endpoint | TE [95% CI] | p val | I2 | n | k | trials |
|---|
| cardiovascular events | no data | | Cardiovascular death | no data | | myocardial infarction (fatal and non fatal) | no data | | stroke (fatal and non fatal) | no data | | Coronary event | no data | | Non vascular death | no data | | Fatal MI | no data | | Non fatal MI | no data | | All cause death | no data | | Fatal stroke | no data | | Non fatal stroke | no data | | new-onset diabetes | no data |
TE: treatment effect; CI: confidence interval; k: nulmber of trials; n: total number of patients |
